Immunological insights on influenza infection and vaccination during immune checkpoint blockade in cancer patients

Immunological insights on influenza infection and vaccination during immune checkpoint blockade in cancer patients

(2020) Melissa Bersanelli et al.   Immunotherapy

State of the art about influenza vaccination for advanced cancer patients receiving immune checkpoint inhibitors: When common sense is not enough

(2019) Melissa Bersanelli et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Immune-mediated adverse events following influenza vaccine in cancer patients receiving immune checkpoint inhibitors

(2019) Morgan E Gwynn et al.   JOURNAL OF ONCOLOGY PHARMACY PRACTICE

Immunogenicity of influenza vaccination in patients with cancer receiving immune checkpoint inhibitor

(2019) Bhumsuk Keam et al.   CLINICAL INFECTIOUS DISEASES

Estimates of global seasonal influenza-associated respiratory mortality: a modelling study

(2018) A Danielle Iuliano et al.   LANCET

Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events

(2018) Heinz Läubli et al.   Journal for ImmunoTherapy of Cancer

Cell culture-derived influenza vaccines in the severe 2017–2018 epidemic season: a step towards improved influenza vaccine effectiveness

(2018) Ian G. Barr et al.   npj Vaccines

Influenza vaccination in patients with lung cancer receiving anti–programmed death receptor 1 immunotherapy does not induce immune-related adverse events

(2018) Dirk H. Wijn et al.   EUROPEAN JOURNAL OF CANCER

INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study

(2018) Melissa Bersanelli et al.   Immunotherapy

Kaposi’s varicelliform eruption in a patient with metastatic melanoma and primary cutaneous anaplastic large cell lymphoma treated with talimogene laherparepvec and nivolumab

(2018) David M. Miller et al.   Journal for ImmunoTherapy of Cancer

Role of Distinct Natural Killer Cell Subsets in Anticancer Response

(2017) Helena Stabile et al.   Frontiers in Immunology

Platelet-mediated shedding of NKG2D ligands impairs NK cell immune-surveillance of tumor cells

(2017) Stefanie Maurer et al.   OncoImmunology

Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab

(2016) A. Martens et al.   CLINICAL CANCER RESEARCH

Mesenchymal stem cells are enriched in head neck squamous cell carcinoma, correlates with tumour size and inhibit T-cell proliferation

(2015) F Liotta et al.   BRITISH JOURNAL OF CANCER

Influenza vaccination perception and coverage among patients with malignant disease

(2015) Wolfgang Poeppl et al.   VACCINE

Clearance of influenza virus infections by T cells: risk of collateral damage?

(2013) MLB Hillaire et al.   Current Opinion in Virology

A multicenter study of pandemic influenza A (H1N1) infection in patients with solid tumors in 3 countries

(2012) Roy F. Chemaly et al.   CANCER

Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study

(2012) Karen Barnett et al.   LANCET

Frequency of regulatory T cells in peripheral blood and in tumour-infiltrating lymphocytes correlates with poor prognosis in renal cell carcinoma

(2010) Francesco Liotta et al.   BJU INTERNATIONAL

PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+CD25Hi regulatory T cells

(2009) Wenshi Wang et al.   INTERNATIONAL IMMUNOLOGY

Regulatory T cells: how do they suppress immune responses?

(2009) S. Sakaguchi et al.   INTERNATIONAL IMMUNOLOGY

Low influenza vaccination rate among patients receiving chemotherapy for cancer

(2008) P. Loulergue et al.   ANNALS OF ONCOLOGY

Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways

(2008) Brian T. Fife et al.   IMMUNOLOGICAL REVIEWS